Bliss GVS Pharma Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Bliss GVS Pharma.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 18.7% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking
Apr 27
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06Is Bliss GVS Pharma (NSE:BLISSGVS) A Risky Investment?
Oct 25Is Bliss GVS Pharma Limited's (NSE:BLISSGVS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?
Oct 07How Much Is Bliss GVS Pharma Limited (NSE:BLISSGVS) CEO Getting Paid?
Sep 19What Is The Ownership Structure Like For Bliss GVS Pharma Limited (NSE:BLISSGVS)?
Sep 04Have Insiders Been Buying Bliss GVS Pharma Limited (NSE:BLISSGVS) Shares?
Aug 17The Bliss GVS Pharma (NSE:BLISSGVS) Share Price Has Gained 43% And Shareholders Are Hoping For More
Aug 04Fewer Investors Than Expected Jumping On Bliss GVS Pharma Limited (NSE:BLISSGVS)
Aug 04Bliss GVS Pharma (NSE:BLISSGVS) Seems To Use Debt Quite Sensibly
Jul 21Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Jul 06In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Bliss GVS Pharma has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2023 | 7,569 | 879 | N/A | N/A | N/A |
| 9/30/2023 | 7,619 | 883 | 505 | 1,026 | N/A |
| 6/30/2023 | 7,224 | 598 | N/A | N/A | N/A |
| 3/31/2023 | 7,516 | 709 | -595 | 343 | N/A |
| 12/31/2022 | 7,339 | 871 | N/A | N/A | N/A |
| 9/30/2022 | 7,444 | 91 | N/A | N/A | N/A |
| 6/30/2022 | 7,680 | 165 | N/A | N/A | N/A |
| 3/31/2022 | 7,475 | 150 | 615 | 1,355 | N/A |
| 12/31/2021 | 7,124 | 17 | N/A | N/A | N/A |
| 9/30/2021 | 6,602 | 773 | -86 | 434 | N/A |
| 6/30/2021 | 6,158 | 766 | N/A | N/A | N/A |
| 3/31/2021 | 5,772 | 685 | 548 | 640 | N/A |
| 12/31/2020 | 5,650 | 710 | N/A | N/A | N/A |
| 9/30/2020 | 5,487 | 692 | 873 | 943 | N/A |
| 6/30/2020 | 6,073 | 797 | N/A | N/A | N/A |
| 3/31/2020 | 6,893 | 973 | -126 | 467 | N/A |
| 12/31/2019 | 8,136 | 1,066 | N/A | N/A | N/A |
| 9/30/2019 | 8,861 | 1,087 | -674 | 267 | N/A |
| 6/30/2019 | 9,044 | 1,192 | N/A | N/A | N/A |
| 3/31/2019 | 8,986 | 1,237 | -38 | 400 | N/A |
| 12/31/2018 | 3,788 | 623 | N/A | N/A | N/A |
| 9/30/2018 | 3,543 | 543 | N/A | N/A | N/A |
| 6/30/2018 | 3,521 | 469 | N/A | N/A | N/A |
| 3/31/2018 | 3,720 | 297 | -106 | 176 | N/A |
| 12/31/2017 | 9,063 | 1,098 | N/A | N/A | N/A |
| 9/30/2017 | 9,423 | 1,053 | N/A | N/A | N/A |
| 6/30/2017 | 8,843 | 860 | N/A | N/A | N/A |
| 3/31/2017 | 4,033 | 509 | N/A | 2,895 | N/A |
| 12/31/2016 | 6,711 | 664 | N/A | N/A | N/A |
| 9/30/2016 | 5,755 | 742 | N/A | N/A | N/A |
| 6/30/2016 | 5,911 | 836 | N/A | N/A | N/A |
| 3/31/2016 | 5,469 | 825 | N/A | 1,129 | N/A |
| 3/31/2015 | 4,071 | 599 | N/A | 376 | N/A |
| 3/31/2014 | 3,446 | 410 | N/A | 412 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if BLISSGVS's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if BLISSGVS's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if BLISSGVS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if BLISSGVS's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if BLISSGVS's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if BLISSGVS's Return on Equity is forecast to be high in 3 years time